Loading…
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Loading…
Tender ID
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Status |
|---|---|---|
| 1 | Accepted-Technical | Accepted-Technical Accepted |
| 2 | Accepted-Technical WOCKHARDT TOWERS BANDRA KURLA COMPLEX BANDRA EAST MUMBAI MAHARASHTRA 400051 | MUMBAI SUBURBAN | MAHARASHTRA | 400051 | Accepted-Technical Accepted |
Tender Value
Refer Docs
Closing Date
3 Oct 2024, 10:00 amClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
DDG (Prov), O/o DGAFMS
DDG(Prov) O/o DGAFMS Ministry of Defence 5th Floor, A Block, Defence Offices Complex Africa Avenue New Delhi 110023
Supply of PVMS No 011992, Human Insulin Analogue Glargine Inj, 100 IU/ml (Recombinant DNA origin) 300 IU Disposable Pen with 5 needles per pen
2024_ARMY_670805_1
RC/24-25/103
Open Tender
Drugs and Pharmaceutical Products
Buy
30 days
New Delhi
As per RFP
6 documents required · 6 mandatory
₹0
Exempted
18 Nov 2024
3 Sept 2024
3 Oct 2024
3 Sept 2024
3 Oct 2024
17 Sept 2024
3 Sept 2024 - 17 Sept 2024
stage.html
html • 0.03 MB
tech_bid_open.pdf
tech_eval.pdf
cancelled_1.pdf
pdf • 0.08 MB
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.04 MB
Tendernotice_1.pdf
PDF • 0.66 MB
BOQ_749942.xls
BOQ • 0.25 MB
AdditionalInfoOnGST.xls
Additional Documents • 0.03 MB
AdditionalDocument.pdf
Additional Documents • 0.16 MB
RFP.pdf
Tender Documents • 0.83 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .